Literature DB >> 28146670

The Antigenicity of the Tumor Cell - Context Matters.

Vessela N Kristensen1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28146670     DOI： 10.1056/NEJMcibr1613793

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence.

Authors:  Ying Xu; Guan-Hua Su; Ding Ma; Yi Xiao; Zhi-Ming Shao; Yi-Zhou Jiang
Journal:  Signal Transduct Target Ther       Date:  2021-08-20

Review 2.  Exosomes: Definition, Role in Tumor Development and Clinical Implications.

Authors:  Alberto Carretero-González; Irene Otero; Lucía Carril-Ajuria; Guillermo de Velasco; Luis Manso
Journal:  Cancer Microenviron       Date:  2018-05-03

3.  Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.

Authors:  Michael T Tetzlaff; Kelly C Nelson; Adi Diab; Gregg A Staerkel; Priyadharsini Nagarajan; Carlos A Torres-Cabala; Beth A Chasen; Jennifer A Wargo; Victor G Prieto; Rodabe N Amaria; Jonathan L Curry
Journal:  J Immunother Cancer       Date:  2018-02-12       Impact factor: 13.751

4.  INeo-Epp: A Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method Based on Sequence-Related Amino Acid Features.

Authors:  Guangzhi Wang; Huihui Wan; Xingxing Jian; Yuyu Li; Jian Ouyang; Xiaoxiu Tan; Yong Zhao; Yong Lin; Lu Xie
Journal:  Biomed Res Int       Date:  2020-06-15       Impact factor: 3.411

5.  T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.

Authors:  Kai-Rong Lin; Fei-Wen Deng; Ya-Bin Jin; Xiang-Ping Chen; Ying-Ming Pan; Jin-Huan Cui; Zhi-Xuan You; Huan-Wei Chen; Wei Luo
Journal:  Cancer Med       Date:  2018-06-26       Impact factor: 4.452

Review 6.  Neoantigen vaccine: an emerging tumor immunotherapy.

Authors:  Miao Peng; Yongzhen Mo; Yian Wang; Pan Wu; Yijie Zhang; Fang Xiong; Can Guo; Xu Wu; Yong Li; Xiaoling Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2019-08-23       Impact factor: 27.401

7.  The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.

Authors:  Pei Zhou; Xueying Wu; Huan Chen; Ying Hu; Henghui Zhang; Lijia Wu; Ying Yang; Beibei Mao; Huaqing Wang
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

Review 8.  T-Cell Immunity in Pancreatic Cancer.

Authors:  Reham Ajina; Louis M Weiner
Journal:  Pancreas       Date:  2020-09       Impact factor: 3.243

Review 9.  T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies.

Authors:  Valérie Janelle; Caroline Rulleau; Simon Del Testa; Cédric Carli; Jean-Sébastien Delisle
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

10.  dbPepNeo: a manually curated database for human tumor neoantigen peptides.

Authors:  Xiaoxiu Tan; Daixi Li; Pengjie Huang; Xingxing Jian; Huihui Wan; Guangzhi Wang; Yuyu Li; Jian Ouyang; Yong Lin; Lu Xie
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.